ID   FPR1_HUMAN              Reviewed;         350 AA.
AC   P21462; Q14939; Q7Z6A4; Q86U52; Q9NS48;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   09-FEB-2010, sequence version 3.
DT   28-JUN-2023, entry version 213.
DE   RecName: Full=fMet-Leu-Phe receptor;
DE            Short=fMLP receptor;
DE   AltName: Full=N-formyl peptide receptor;
DE            Short=FPR;
DE   AltName: Full=N-formylpeptide chemoattractant receptor;
GN   Name=FPR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND VARIANTS LEU-101 AND ALA-346.
RX   PubMed=2161213; DOI=10.1016/0006-291x(90)91143-g;
RA   Boulay F., Tardif M., Brouchon L., Vignais P.;
RT   "Synthesis and use of a novel N-formyl peptide derivative to isolate a
RT   human N-formyl peptide receptor cDNA.";
RL   Biochem. Biophys. Res. Commun. 168:1103-1109(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND VARIANTS
RP   LEU-101 AND ALA-346.
RX   PubMed=2176894; DOI=10.1021/bi00502a016;
RA   Boulay F., Tardif M., Brouchon L., Vignais P.;
RT   "The human N-formylpeptide receptor. Characterization of two cDNA isolates
RT   and evidence for a new subfamily of G-protein-coupled receptors.";
RL   Biochemistry 29:11123-11133(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=1712023; DOI=10.1016/s0021-9258(18)98935-0;
RA   Murphy P.M., McDermott D.;
RT   "Functional expression of the human formyl peptide receptor in Xenopus
RT   oocytes requires a complementary human factor.";
RL   J. Biol. Chem. 266:12560-12567(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT LYS-192.
RX   PubMed=1612600; DOI=10.1016/0888-7543(92)90265-t;
RA   Bao L., Gerard N.P., Eddy R.L. Jr., Shows T.B., Gerard C.;
RT   "Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor
RT   (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to
RT   chromosome 19.";
RL   Genomics 13:437-440(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-346.
RA   Perez H.D.;
RL   Submitted (MAR-1993) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8224916; DOI=10.1016/0378-1119(93)90653-k;
RA   Murphy P.M., Tiffany H.L., McDermott D., Ahuja S.K.;
RT   "Sequence and organization of the human N-formyl peptide receptor-encoding
RT   gene.";
RL   Gene 133:285-290(1993).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS THR-11 AND LYS-192.
RA   Kopatz S.A., Aronstam R.S., Sharma S.V.;
RT   "cDNA clones of human proteins involved in signal transduction sequenced by
RT   the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-5.
RC   TISSUE=Bone marrow;
RX   PubMed=1445895; DOI=10.1021/bi00161a044;
RA   Perez H.D., Holmes R., Kelly E., McClary J., Chou Q., Andrews W.H.;
RT   "Cloning of the gene coding for a human receptor for formyl peptides.
RT   Characterization of a promoter region and evidence for polymorphic
RT   expression.";
RL   Biochemistry 31:11595-11599(1992).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-328; THR-329;
RP   THR-331; SER-332; THR-334; THR-336; SER-338 AND THR-339.
RX   PubMed=10514456; DOI=10.1074/jbc.274.42.29791;
RA   Maestes D.C., Potter R.M., Prossnitz E.R.;
RT   "Differential phosphorylation paradigms dictate desensitization and
RT   internalization of the N-formyl peptide receptor.";
RL   J. Biol. Chem. 274:29791-29795(1999).
RN   [13]
RP   FUNCTION, INTERACTION WITH CHIPS, AND SUBCELLULAR LOCATION.
RX   PubMed=15153520; DOI=10.4049/jimmunol.172.11.6994;
RA   Postma B., Poppelier M.J.J.G., van Galen J.C., Prossnitz E.R.,
RA   van Strijp J.A.G., de Haas C.J.C., van Kessel K.P.M.;
RT   "Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically
RT   to the C5a and formylated peptide receptor.";
RL   J. Immunol. 172:6994-7001(2004).
RN   [14]
RP   FUNCTION.
RX   PubMed=15210802; DOI=10.4049/jimmunol.173.1.428;
RA   Sun R., Iribarren P., Zhang N., Zhou Y., Gong W., Cho E.H., Lockett S.,
RA   Chertov O., Bednar F., Rogers T.J., Oppenheim J.J., Wang J.M.;
RT   "Identification of neutrophil granule protein cathepsin G as a novel
RT   chemotactic agonist for the G protein-coupled formyl peptide receptor.";
RL   J. Immunol. 173:428-436(2004).
RN   [15]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25109685; DOI=10.1038/cmi.2014.61;
RA   Wang W., Li T., Wang X., Yuan W., Cheng Y., Zhang H., Xu E., Zhang Y.,
RA   Shi S., Ma D., Han W.;
RT   "FAM19A4 is a novel cytokine ligand of formyl peptide receptor 1 (FPR1) and
RT   is able to promote the migration and phagocytosis of macrophages.";
RL   Cell. Mol. Immunol. 12:615-624(2015).
CC   -!- FUNCTION: High affinity receptor for N-formyl-methionyl peptides
CC       (fMLP), which are powerful neutrophil chemotactic factors
CC       (PubMed:2161213, PubMed:2176894, PubMed:10514456, PubMed:15153520).
CC       Binding of fMLP to the receptor stimulates intracellular calcium
CC       mobilization and superoxide anion release (PubMed:2161213,
CC       PubMed:1712023, PubMed:15153520, PubMed:15210802). This response is
CC       mediated via a G-protein that activates a phosphatidylinositol-calcium
CC       second messenger system (PubMed:1712023, PubMed:10514456). Receptor for
CC       TAFA4, mediates its effects on chemoattracting macrophages, promoting
CC       phagocytosis and increasing ROS release (PubMed:25109685). Receptor for
CC       cathepsin CTSG, leading to increased phagocyte chemotaxis
CC       (PubMed:15210802). {ECO:0000269|PubMed:10514456,
CC       ECO:0000269|PubMed:15153520, ECO:0000269|PubMed:2161213,
CC       ECO:0000269|PubMed:2176894, ECO:0000269|PubMed:25109685,
CC       ECO:0000303|PubMed:10514456, ECO:0000303|PubMed:1712023,
CC       ECO:0000303|PubMed:2161213, ECO:0000303|PubMed:2176894}.
CC   -!- SUBUNIT: Interacts with S.aureus chemotaxis inhibitory protein (CHIPS);
CC       the interaction blocks the receptor and may thus inhibit the immune
CC       response. {ECO:0000269|PubMed:15153520}.
CC   -!- INTERACTION:
CC       P21462; P25098: GRK2; NbExp=3; IntAct=EBI-2869495, EBI-3904795;
CC       P21462; O15264: MAPK13; NbExp=3; IntAct=EBI-2869495, EBI-2116951;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15153520,
CC       ECO:0000269|PubMed:2176894, ECO:0000269|PubMed:25109685,
CC       ECO:0000305|PubMed:10514456}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Internalizes in presence of its ligands, fMLP,
CC       TAFA4 and CTSG. {ECO:0000269|PubMed:15210802,
CC       ECO:0000269|PubMed:25109685}.
CC   -!- TISSUE SPECIFICITY: Neutrophils.
CC   -!- PTM: Phosphorylated; which is necessary for desensitization.
CC       {ECO:0000269|PubMed:10514456}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/44328/FPR1";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M37128; AAA36362.1; -; mRNA.
DR   EMBL; M60626; AAA35846.1; -; mRNA.
DR   EMBL; M60627; AAA35847.1; -; mRNA.
DR   EMBL; L10820; AAA16863.1; -; Genomic_DNA.
DR   EMBL; AY301273; AAP58403.1; -; Genomic_DNA.
DR   EMBL; BT007429; AAP36097.1; -; mRNA.
DR   EMBL; AC018755; AAF87842.1; -; Genomic_DNA.
DR   EMBL; BC005315; AAH05315.1; -; mRNA.
DR   EMBL; S49810; AAD14906.1; -; mRNA.
DR   CCDS; CCDS12839.1; -.
DR   PIR; JC2014; A42009.
DR   RefSeq; NP_001180235.1; NM_001193306.1.
DR   RefSeq; NP_002020.1; NM_002029.3.
DR   PDB; 7EUO; EM; 2.90 A; R=1-350.
DR   PDB; 7T6T; EM; 3.20 A; R=1-333.
DR   PDB; 7VFX; EM; 2.80 A; R=1-350.
DR   PDB; 7WVU; EM; 3.30 A; R=2-321.
DR   PDBsum; 7EUO; -.
DR   PDBsum; 7T6T; -.
DR   PDBsum; 7VFX; -.
DR   PDBsum; 7WVU; -.
DR   AlphaFoldDB; P21462; -.
DR   SMR; P21462; -.
DR   BioGRID; 108640; 152.
DR   IntAct; P21462; 4.
DR   STRING; 9606.ENSP00000471493; -.
DR   BindingDB; P21462; -.
DR   ChEMBL; CHEMBL3359; -.
DR   DrugBank; DB00716; Nedocromil.
DR   DrugCentral; P21462; -.
DR   GuidetoPHARMACOLOGY; 222; -.
DR   GlyCosmos; P21462; 2 sites, No reported glycans.
DR   GlyGen; P21462; 2 sites.
DR   iPTMnet; P21462; -.
DR   PhosphoSitePlus; P21462; -.
DR   BioMuta; FPR1; -.
DR   DMDM; 288558848; -.
DR   EPD; P21462; -.
DR   jPOST; P21462; -.
DR   MassIVE; P21462; -.
DR   PaxDb; P21462; -.
DR   PeptideAtlas; P21462; -.
DR   ProteomicsDB; 53872; -.
DR   ABCD; P21462; 8 sequenced antibodies.
DR   Antibodypedia; 19049; 479 antibodies from 33 providers.
DR   DNASU; 2357; -.
DR   Ensembl; ENST00000304748.5; ENSP00000302707.3; ENSG00000171051.10.
DR   Ensembl; ENST00000594900.2; ENSP00000470750.2; ENSG00000171051.10.
DR   Ensembl; ENST00000595042.5; ENSP00000471493.1; ENSG00000171051.10.
DR   Ensembl; ENST00000600815.2; ENSP00000472936.2; ENSG00000171051.10.
DR   GeneID; 2357; -.
DR   KEGG; hsa:2357; -.
DR   MANE-Select; ENST00000304748.5; ENSP00000302707.3; NM_002029.4; NP_002020.1.
DR   UCSC; uc002pxq.4; human.
DR   AGR; HGNC:3826; -.
DR   CTD; 2357; -.
DR   DisGeNET; 2357; -.
DR   GeneCards; FPR1; -.
DR   HGNC; HGNC:3826; FPR1.
DR   HPA; ENSG00000171051; Tissue enhanced (bone marrow, lymphoid tissue).
DR   MalaCards; FPR1; -.
DR   MIM; 136537; gene.
DR   neXtProt; NX_P21462; -.
DR   OpenTargets; ENSG00000171051; -.
DR   Orphanet; 447740; Susceptibility to localized juvenile periodontitis.
DR   PharmGKB; PA28244; -.
DR   VEuPathDB; HostDB:ENSG00000171051; -.
DR   eggNOG; KOG3656; Eukaryota.
DR   GeneTree; ENSGT01020000230336; -.
DR   InParanoid; P21462; -.
DR   OMA; GWFMCKF; -.
DR   OrthoDB; 5384006at2759; -.
DR   PhylomeDB; P21462; -.
DR   TreeFam; TF330976; -.
DR   BRENDA; 3.1.4.4; 2681.
DR   PathwayCommons; P21462; -.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   Reactome; R-HSA-444473; Formyl peptide receptors bind formyl peptides and many other ligands.
DR   Reactome; R-HSA-6783783; Interleukin-10 signaling.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; P21462; -.
DR   SIGNOR; P21462; -.
DR   BioGRID-ORCS; 2357; 9 hits in 1143 CRISPR screens.
DR   ChiTaRS; FPR1; human.
DR   GeneWiki; Formyl_peptide_receptor_1; -.
DR   GenomeRNAi; 2357; -.
DR   Pharos; P21462; Tchem.
DR   PRO; PR:P21462; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; P21462; protein.
DR   Bgee; ENSG00000171051; Expressed in blood and 142 other tissues.
DR   ExpressionAtlas; P21462; baseline and differential.
DR   Genevisible; P21462; HS.
DR   GO; GO:0035577; C:azurophil granule membrane; TAS:Reactome.
DR   GO; GO:0005737; C:cytoplasm; ISS:ARUK-UCL.
DR   GO; GO:0101003; C:ficolin-1-rich granule membrane; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; ISS:ARUK-UCL.
DR   GO; GO:0030667; C:secretory granule membrane; TAS:Reactome.
DR   GO; GO:0004875; F:complement receptor activity; IBA:GO_Central.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IDA:UniProtKB.
DR   GO; GO:0001664; F:G protein-coupled receptor binding; IDA:UniProtKB.
DR   GO; GO:0004982; F:N-formyl peptide receptor activity; IDA:MGI.
DR   GO; GO:0050786; F:RAGE receptor binding; IEA:Ensembl.
DR   GO; GO:0005124; F:scavenger receptor binding; IEA:Ensembl.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0006935; P:chemotaxis; TAS:ProtInc.
DR   GO; GO:0002430; P:complement receptor mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0006954; P:inflammatory response; IBA:GO_Central.
DR   GO; GO:0007263; P:nitric oxide mediated signal transduction; TAS:ProtInc.
DR   GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; IDA:MGI.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR000826; Formyl_rcpt-rel.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR24225; CHEMOTACTIC RECEPTOR; 1.
DR   PANTHER; PTHR24225:SF60; FMET-LEU-PHE RECEPTOR; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00526; FMETLEUPHER.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Chemotaxis; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Phosphoprotein;
KW   Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..350
FT                   /note="fMet-Leu-Phe receptor"
FT                   /id="PRO_0000069444"
FT   TOPO_DOM        1..27
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        28..50
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        51..61
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        62..83
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        84..100
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        101..121
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        122..140
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        141..162
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        163..205
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        206..226
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        227..242
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        243..266
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        267..285
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        286..305
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        306..350
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          325..350
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         328
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         329
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         331
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         332
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         334
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         336
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         338
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         339
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        4
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        10
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        98..176
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   VARIANT         11
FT                   /note="I -> T (in dbSNP:rs5030878)"
FT                   /evidence="ECO:0000269|Ref.7"
FT                   /id="VAR_055915"
FT   VARIANT         101
FT                   /note="V -> L (in dbSNP:rs2070745)"
FT                   /evidence="ECO:0000269|PubMed:2161213,
FT                   ECO:0000269|PubMed:2176894"
FT                   /id="VAR_003476"
FT   VARIANT         190
FT                   /note="R -> W (in dbSNP:rs5030880)"
FT                   /id="VAR_055916"
FT   VARIANT         192
FT                   /note="N -> K (in dbSNP:rs1042229)"
FT                   /evidence="ECO:0000269|PubMed:1612600, ECO:0000269|Ref.7"
FT                   /id="VAR_003477"
FT   VARIANT         346
FT                   /note="E -> A (in dbSNP:rs867228)"
FT                   /evidence="ECO:0000269|PubMed:2161213,
FT                   ECO:0000269|PubMed:2176894, ECO:0000269|Ref.5"
FT                   /id="VAR_003478"
FT   CONFLICT        238
FT                   /note="R -> P (in Ref. 1; AAA36362)"
FT                   /evidence="ECO:0000305"
FT   HELIX           23..53
FT                   /evidence="ECO:0007829|PDB:7VFX"
FT   HELIX           59..75
FT                   /evidence="ECO:0007829|PDB:7VFX"
FT   HELIX           78..86
FT                   /evidence="ECO:0007829|PDB:7VFX"
FT   TURN            87..89
FT                   /evidence="ECO:0007829|PDB:7VFX"
FT   HELIX           95..128
FT                   /evidence="ECO:0007829|PDB:7VFX"
FT   HELIX           130..136
FT                   /evidence="ECO:0007829|PDB:7VFX"
FT   HELIX           139..145
FT                   /evidence="ECO:0007829|PDB:7VFX"
FT   HELIX           147..163
FT                   /evidence="ECO:0007829|PDB:7VFX"
FT   STRAND          164..169
FT                   /evidence="ECO:0007829|PDB:7VFX"
FT   TURN            170..172
FT                   /evidence="ECO:0007829|PDB:7VFX"
FT   STRAND          173..178
FT                   /evidence="ECO:0007829|PDB:7VFX"
FT   HELIX           187..208
FT                   /evidence="ECO:0007829|PDB:7VFX"
FT   HELIX           211..230
FT                   /evidence="ECO:0007829|PDB:7VFX"
FT   HELIX           237..266
FT                   /evidence="ECO:0007829|PDB:7VFX"
FT   HELIX           268..272
FT                   /evidence="ECO:0007829|PDB:7VFX"
FT   HELIX           278..302
FT                   /evidence="ECO:0007829|PDB:7VFX"
FT   HELIX           306..314
FT                   /evidence="ECO:0007829|PDB:7VFX"
SQ   SEQUENCE   350 AA;  38446 MW;  06651DF820B1CBD1 CRC64;
     METNSSLPTN ISGGTPAVSA GYLFLDIITY LVFAVTFVLG VLGNGLVIWV AGFRMTHTVT
     TISYLNLAVA DFCFTSTLPF FMVRKAMGGH WPFGWFLCKF VFTIVDINLF GSVFLIALIA
     LDRCVCVLHP VWTQNHRTVS LAKKVIIGPW VMALLLTLPV IIRVTTVPGK TGTVACTFNF
     SPWTNDPKER INVAVAMLTV RGIIRFIIGF SAPMSIVAVS YGLIATKIHK QGLIKSSRPL
     RVLSFVAAAF FLCWSPYQVV ALIATVRIRE LLQGMYKEIG IAVDVTSALA FFNSCLNPML
     YVFMGQDFRE RLIHALPASL ERALTEDSTQ TSDTATNSTL PSAEVELQAK
//
